There's good reason to consider buying shares in these biotech companies soon.
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
Key Data Points
Primary metrics and data points about Arena Pharmaceuticals.Current Price: | $39.69 |
Prev Close: | $39.27 |
Open: | $39.39 |
Bid: | $39.01 |
Ask: | $39.79 |
Day's Range: | $38.82 - $39.82 |
52wk Range: | $11.30 - $45.85 |
Volume: | 719,917 |
Avg Vol | 2,207,725 |
Market Cap: | $2B |
P/E (ttm): | -13.68 |
EPS (ttm): | ($2.87) |
Div & Yield: | $0.00 (0.0%) |
Company Rating
What our community thinks about Arena Pharmaceuticals.Business Summary
Industry, sector and description for Arena Pharmaceuticals.A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Drug Makers